Phosphoproteomics-based modeling defines the regulatory mechanism underlying aberrant EGFR signaling.
Tasaki S, Nagasaki M, Kozuka-Hata H, Semba K, Gotoh N, Hattori S, Inoue J, Yamamoto T, Miyano S, Sugano S, et al. PLoS One. 2010 Nov 10; 5(11):e13926. Epub 2010 Nov 10.